Cargando…

Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray

PURPOSE: Prediction of response to primary endocrine therapy (PET) in older women is based on measurement of oestrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor (HER)-2. This study uses a unique method for construction of core needle biopsy (CNB) tissue microarray...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parks, R. M., Albanghali, M. A., Syed, B. M., Green, A. R., Ellis, I. O., Cheung, K-L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921046/ https://www.ncbi.nlm.nih.gov/pubmed/33226492 http://dx.doi.org/10.1007/s10549-020-06023-4

Ejemplares similares

Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome
por: Parks, Ruth M., et al.
Publicado: (2020)

Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
por: Qi, Peng, et al.
Publicado: (2021)

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
por: Muftah, Abir A., et al.
Publicado: (2017)

SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2021)

Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group
por: Jung, Chan Kwon, et al.
Publicado: (2015)

Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
por: Leal, Mariana Ferreira, et al.
Publicado: (2019)

The significance of lobular neoplasia on needle core biopsy of the breast
por: Menon, S., et al.
Publicado: (2008)

Needle core biopsy for breast lesions: An audit of 467 needle core biopsies
por: Radhakrishna, Selvi, et al.
Publicado: (2013)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Construction of tissue microarrays from prostate needle biopsy specimens
por: Jhavar, S, et al.
Publicado: (2005)

Combination of needle aspiration and core needle biopsy: A new technique of stereotactic biopsy
por: Wani, Abrar Ahad, et al.
Publicado: (2016)

Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation
por: Kwok, T’ng Chang, et al.
Publicado: (2010)

Connexin 43 is an independent predictor of patient outcome in breast cancer patients
por: Chasampalioti, Maria, et al.
Publicado: (2018)

Clinical endpoints of needle‐free jet injector treatment: An in depth understanding of immediate skin responses
por: Bik, Liora, et al.
Publicado: (2022)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
por: Harrell, J. Chuck, et al.
Publicado: (2011)

Characterization of a Unique Form of Arrhythmic Cardiomyopathy Caused by Recessive Mutation in LEMD2
por: Abdelfatah, Nelly, et al.
Publicado: (2019)

Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
por: Goley, Elizabeth M, et al.
Publicado: (2004)

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
por: Andreano, Kaitlyn J., et al.
Publicado: (2020)

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
por: Green, Andrew R., et al.
Publicado: (2016)

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
por: Ahmad, Dena A. J., et al.
Publicado: (2016)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
por: Al-Subhi, Nouf, et al.
Publicado: (2018)

Biological and clinical significance of PARP1 protein expression in breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Current status of core needle biopsy of the thyroid
por: Baek, Jung Hwan
Publicado: (2017)

The 2019 core-needle biopsy practice guidelines
por: Jeong, So Yeong, et al.
Publicado: (2020)

High-density tissue microarrays from prostate needle biopsies
por: McCarthy, F, et al.
Publicado: (2010)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

An improved method for constructing tissue microarrays from prostate needle biopsy specimens
por: McCarthy, F, et al.
Publicado: (2009)

PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
por: Fan, Yu, et al.
Publicado: (2022)

Phenotypic characterisation of breast cancer: the role of CDC42
por: Chrysanthou, Eleni, et al.
Publicado: (2017)

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
por: Kariri, Yousif, et al.
Publicado: (2022)

Antitumor activity of recombinant RGD-IFN-α2a-core fusion protein in vitro
por: Wen, Zhengwei, et al.
Publicado: (2017)

Comparison between core needle biopsy and excisional biopsy for breast neoplasm
por: Sun, Chunjie, et al.
Publicado: (2021)

New Insights in Peripheral Arterial Disease: Novel In Silico Mouse and Disease-Based Computational Models
por: Hakim, Ali H., et al.
Publicado: (2022)

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients
por: Mirza, Sameer, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8mr5k564b0gvb3225v3kfu5glg